Riggs Asset Managment »

Kiniksa Pharmaceuticals shares owned by Riggs Asset Managment

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Riggs Asset Managment from 13F filings

Historical chart of Riggs Asset Managment investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Riggs Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Riggs Asset Managment

Quarter filed Position value Share count Share price at filing
2024-03-31 $591 30 19.73

More positions owned by Riggs Asset Managment

Global X Fds Us Infr Dev Etf (PAVE)
Ishares Tr Us Home Cons Etf (ITB)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Expanded Tech (IGV)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded Rba Indl Etf (AIRR)
Ishares Tr Core S&p Mcp Etf (IJH)
Visa Com Cl A (V)
Select Sector Spdr Tr Energy (XLE)
Alps Etf Tr Alerian Mlp (AMLP)
Apple (AAPL)
Asml Holding N V N Y Registry Shs (ASML)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vaneck Etf Trust Steel Etf (SLX)

View all positions for Riggs Asset Managment

Top funds holding Kiniksa Pharmaceuticals

BlackRock
Fairmount Funds Management
Vanguard Group
Baker Bros. Advisors
Rubric Capital Management
Pictet Asset Management Holding SA
Braidwell
Morgan Stanley
Nuveen Asset Management
Goldman Sachs Group
Geode Capital Management
Arrowpoint Asset Management
Granahan Investment Management
Parkman Healthcare Partners
Rice Hall James & Associates

View all funds holding Kiniksa Pharmaceuticals